HumanexaHumanexaHumanexa
WelcomeSignalsCompaniesScenario AnalysisRegulatoryStrategy

Library

InsightsNewslettersReportsBriefings
Pricing

Workspace

Workspace

Free

Intelligence Active

FDA source evidence

ANDA205071

FDA application evidence

ANDA205071

MILNACIPRAN HYDROCHLORIDE

Application summary

Application number
ANDA205071
Sponsor
BRECKENRIDGE
Product / brand name
MILNACIPRAN HYDROCHLORIDE
Active ingredients
MILNACIPRAN HYDROCHLORIDE
Submission type
SUPPL
Submission status
AP
Submission date
20260414
Review priority
STANDARD
Dosage form
TABLET
Route
ORAL
Marketing status
Prescription
TE code
AB
View raw openFDA evidence
PrivacyTermsRefund PolicyDisclaimer

© 2026 Humanexa. Intelligence for research workflows — not medical, legal, regulatory filing, or investment advice.